ZBTB7A and cholangiocarcinoma: After 48 hr of drug treatment, the expression of PCNA, Bcl-2, ZBTB7A, p-p65, and p65 in the CC group and PTX group was dramatically lower than that in the Control group, and the CC+PTX group showed the lowest protein expression (Figure 4).